Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality

Science

Volumn 348, Issue 6235, 2015, Pages 694-699

  Mina, Michael J ^a,b   Metcalf, C Jessica E ^a,c   De Swart, Rik L ^d   Osterhaus, A D M E ^d   Grenfell, Bryan T ^a,c  

^a PRINCETON UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

CHILD HEALTH; DISEASE INCIDENCE; IMMUNE RESPONSE; INFECTIOUS DISEASE; MEASLES; MORTALITY; VACCINATION;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; EPIDEMIC; HERD IMMUNITY; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; LYMPHOCYTE DEPLETION; MASS IMMUNIZATION; MEASLES; MEASLES VACCINATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; CHILD; FEMALE; IMMUNOLOGY; INCIDENCE; MALE; MORTALITY; OPPORTUNISTIC INFECTIONS; PRESCHOOL CHILD; TIME; UNITED KINGDOM; UNITED STATES; VACCINATION;

B-LYMPHOCYTES; CHILD; CHILD MORTALITY; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOMODULATION; INCIDENCE; LYMPHOCYTE DEPLETION; MALE; MEASLES; MEASLES VACCINE; OPPORTUNISTIC INFECTIONS; T-LYMPHOCYTES; TIME FACTORS; UNITED STATES; VACCINATION; WALES;

EID: 84929093770     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaa3662     Document Type: Article

References (40)

1. W. J. Moss, D. E. Griffin, Lancet 379, 153-164 (2012).
2. E. Simons et al., Lancet 379, 2173-2178 (2012).
3. R. T. Perry et al., MMWR Morb. Mortal. Wkly. Rep. 63, 103-107 (2014).
4. S. B. Omer, D. A. Salmon, W. A. Orenstein, M. P. deHart, N. Halsey, N. Engl. J. Med. 360, 1981-1988 (2009).
5. J. D. Clemens et al., Am. J. Epidemiol. 128, 1330-1339 (1988).
6. M. A. Koenig et al., Bull. World Health Organ. 68, 441-447 (1990).
7. A. Desgrées du LoÛ, G. Pison, P. Aaby, Am. J. Epidemiol. 142, 643-652 (1995).
8. P. Aaby, J. Bukh, I. M. Lisse, A. J. Smits, J. Infect. 8, 13-21 (1984).
9. E. A. Holt, R. Boulos, N. A. Halsey, L. M. Boulos, C. Boulos, Pediatrics 85, 188-194 (1990).
10. Z. Kabir, J. Long, V. P. Reddaiah, J. Kevany, S. K. Kapoor, Bull. World Health Organ. 81, 244-250 (2003).
11. P. Aaby, T. R. Kollmann, C. S. Benn, Nat. Immunol. 15, 895-899 (2014).
12. P. Aaby et al., Int. J. Epidemiol. 32, 106-115 (2003).
13. K. L. Flanagan et al., Clin. Infect. Dis. 57, 283-289 (2013).
14. C. L. Karp et al., Science 273, 228-231 (1996).
15. B. Hahm, Curr. Top. Microbiol. Immunol. 330, 271-287 (2009).
16. S. Schneider-Schaulies, J. Schneider-Schaulies, Curr. Top. Microbiol. Immunol. 330, 243-269 (2009).
17. R. D. de Vries et al., PLOS Pathog. 8, e1002885 (2012).
18. J. Kleinnijenhuis et al., Proc. Natl. Acad. Sci. U.S.A. 109, 17537-17542 (2012).
19. G. R. Lee, S. T. Kim, C. G. Spilianakis, P. E. Fields, R. A. Flavell, Immunity 24, 369-379 (2006).
20. M. G. Netea, J. Quintin, J. W. van der Meer, Cell Host Microbe 9, 355-361 (2011).
21. S. Saeed et al., Science 345, 1251086 (2014).
22. WHO, Meeting of the Strategic Advisory Group of Experts on immunization, March 2014, Systematic Review of the Non-specific Effects of BCG, DTP and Measles Containing Vaccines, http://www.who.int/immunization/sage/meetings/2014/april/3-NSE-Epidemiology-review-Report-to-SAGE-14-Mar-FINAL.pdf.
23. R. D. de Vries, R. L. de Swart, PLOS Pathog. 10, e1004482 (2014).
24. W. H. Lin, R. D. Kouyos, R. J. Adams, B. T. Grenfell, D. E. Griffin, Proc. Natl. Acad. Sci. U.S.A. 109, 14989-14994 (2012).
25. R. T. Perry, N. A. Halsey, J. Infect. Dis. 189, S4-S16 (2004).
26. L. K. Selin, K. Vergilis, R. M. Welsh, S. R. Nahill, J. Exp. Med. 183, 2489-2499 (1996).
27. S. K. Kim, M. A. Brehm, R. M. Welsh, L. K. Selin, J. Immunol. 169, 90-98 (2002).
28. S. K. Kim, R. M. Welsh, J. Immunol. 172, 3139-3150 (2004).
29. C. D. Peacock, S. K. Kim, R. M. Welsh, J. Immunol. 171, 655-663 (2003).
30. A. R. Hinman, W. A. Orenstein, M. J. Papania, J. Infect. Dis. 189, S17-S22 (2004).
31. P. Aaby, J. Bukh, D. Kronborg, I. M. Lisse, M. C. da Silva, Am. J. Epidemiol. 132, 211-219 (1990).
32. WHO, Global Review of the Distribution of Pneumococcal Invasive Disease by Age and Region (2011); www.who.int/immunization/sage/6-Russel-review-age-specific-epidemiology-PCV-schedules-session-nov11.pdf.
33. O. Horwitz, K. Grünfeld, B. Lysgaard-Hansen, K. Kjeldsen, Am. J. Epidemiol. 100, 136-149 (1974).
34. J. A. Clarkson, P. E. M. Fine, Int. J. Epidemiol. 14, 153-168 (1985).
35. A. Kipps, L. Stern, E. Vaughan, S. Afr. Med. J. 86, 104-108 (1996).
36. S. O. Shaheen et al., BMJ 313, 969-974 (1996).
37. S. O. Shaheen et al., Lancet 347, 1792-1796 (1996).
38. P. Aaby, B. Samb, M. Andersen, F. Simondon, Am. J. Epidemiol. 143, 1035-1041 (1996).
39. P. Aaby, I. M. Lisse, K. Mølbak, K. Knudsen, H. Whittle, Pediatr. Infect. Dis. J. 15, 39-44 (1996).
40. D. J. Earn, P. Rohani, B. M. Bolker, B. T. Grenfell, Science 287, 667-670 (2000).